O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study results

Saved in:
Bibliographic Details
Main Authors: Aneal Khan, Dwayne Barber, William McKillop, Anthony Rupar, Christiane Auray-Blais, Graeme Fraser, Daniel Fowler, Alexandra Berger, Ronan Foley, Armand Keating, Michael West, Jeffrey Medin
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Genetics in Medicine Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2949774425001517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849711960637046784
author Aneal Khan
Dwayne Barber
William McKillop
Anthony Rupar
Christiane Auray-Blais
Graeme Fraser
Daniel Fowler
Alexandra Berger
Ronan Foley
Armand Keating
Michael West
Jeffrey Medin
author_facet Aneal Khan
Dwayne Barber
William McKillop
Anthony Rupar
Christiane Auray-Blais
Graeme Fraser
Daniel Fowler
Alexandra Berger
Ronan Foley
Armand Keating
Michael West
Jeffrey Medin
author_sort Aneal Khan
collection DOAJ
format Article
id doaj-art-7257db364edd4fe9bd1216b3c7dee5e1
institution DOAJ
issn 2949-7744
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Genetics in Medicine Open
spelling doaj-art-7257db364edd4fe9bd1216b3c7dee5e12025-08-20T03:14:28ZengElsevierGenetics in Medicine Open2949-77442025-01-01310211210.1016/j.gimo.2025.102112O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study resultsAneal Khan0Dwayne Barber1William McKillop2Anthony Rupar3Christiane Auray-Blais4Graeme Fraser5Daniel Fowler6Alexandra Berger7Ronan Foley8Armand Keating9Michael West10Jeffrey Medin11M.A.G.I.C. Clinic (Metabolics and Genetics in Canada)Department of Laboratory Medicine and Pathobiology, University of TorontoDepartment of Pediatrics, Medical College of WisconsinDepartment of Pathology and Laboratory Medicine, Western UniversityDepartment of Pediatrics, Division of Medical Genetics, CIUSS de l’Estrie-CHUS Hospital FleurimontDepartment of Oncology, McMaster University and Juravinski Hospital and Cancer CentreRapa TherapeuticsPrincess Margaret Cancer Centre, University Health NetworkDepartment of Pathology and Molecular Medicine, McMaster University and Juravinski Hospital and Cancer CentreDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Princess Margaret Cancer CentreDivision of Nephrology, Department of Medicine, Dalhousie UniversityDepartment of Biochemistry, Medical College of Wisconsinhttp://www.sciencedirect.com/science/article/pii/S2949774425001517
spellingShingle Aneal Khan
Dwayne Barber
William McKillop
Anthony Rupar
Christiane Auray-Blais
Graeme Fraser
Daniel Fowler
Alexandra Berger
Ronan Foley
Armand Keating
Michael West
Jeffrey Medin
O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study results
Genetics in Medicine Open
title O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study results
title_full O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study results
title_fullStr O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study results
title_full_unstemmed O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study results
title_short O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study results
title_sort o36 lentiviral gene therapy for fabry disease in the canadian facts trial 5 year end of study results
url http://www.sciencedirect.com/science/article/pii/S2949774425001517
work_keys_str_mv AT anealkhan o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT dwaynebarber o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT williammckillop o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT anthonyrupar o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT christianeaurayblais o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT graemefraser o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT danielfowler o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT alexandraberger o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT ronanfoley o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT armandkeating o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT michaelwest o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults
AT jeffreymedin o36lentiviralgenetherapyforfabrydiseaseinthecanadianfactstrial5yearendofstudyresults